For an Oracle shareholder, the core belief is that heavy AI infrastructure spending and large remaining performance obligations eventually translate into durable, high margin cloud and database usage. The short term swing factor is whether AI capacity already deployed, including more than 300,000 GPUs at high utilization levels, keeps converting into billable workloads and renewals at acceptable pricing.
The biggest risk is simple: cash goes out faster than it comes in. Net cash CapEx of roughly US$70b planned for FY27, a funding plan that leans on about US$40b of new capital, and rising interest costs can pressure free cash flow if customers slow deployments or renegotiate large AI infrastructure contracts.
The most relevant recent move for this story is UiPath Test Cloud arriving on Oracle Marketplace. That launch puts an AI driven automation vendor directly in front of Oracle customers who care about testing across Fusion, E Business Suite and other Oracle applications. This ties cleanly to the company’s pitch around AI centric enterprise workloads.
For you, the interesting angle is execution risk and adoption speed. Stronger automated testing can help customers roll out Oracle updates and AI features faster, which supports cloud usage and potentially reduces deployment delays that might otherwise push out revenue from large performance obligations. If uptake is slow, the impact on Oracle’s near term catalysts could be modest.
Analysts expect Oracle to generate US$193.6b in revenue and US$47.2b in earnings by 2029, based on an assumed 39.2% yearly revenue growth rate and an earnings increase of about US$28.5b from current earnings of US$18.7b.
Uncover how Oracle's fair value indicates an 86% potential upside to its current price that could narrow quickly if Oracle continues to execute on its AI plans.
One alternate view puts more weight on Oracle’s ability to turn the new OCP security effort into higher value AI contracts. The most optimistic analysts were already penciling in about US$216.9b of 2029 revenue and US$52.5b of earnings. Those estimates came before this hardware security and testing news, so opinions could swing further.
Explore 18 other Oracle fair value estimates, including one that suggests as much as 204% upside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If you want to pressure test your view on Oracle against what else is out there, it helps to scan a wider field of companies with similar qualities. The Simply Wall St Screener lets you quickly line up different profiles side by side so you can see where Oracle fits in your portfolio and where other opportunities might look more compelling.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com